DYAI
DYADIC INTERNATIONAL INC
NASDAQ · Healthcare · Biotechnology · US
$0.42
−2.05%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 14.66x
- P/E 2028E
- —
- P/S forward
- 2.25x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -6.96x
- Price / sales
- 4.79x
- Price / cash flow
- -2.25x
Enterprise value
- Enterprise value
- $18.6M
- EV / sales
- 5.34x
- EV / EBITDA
- -2.58x
- EV / EBIT
- -2.50x
- Market cap
- $16.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026